Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net loss	$ (12,895,044)	$ (5,807,407)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	564,770	540,540
Stock-based compensation expense	2,194,709	1,345,931
Issuance of Common Stock for services	20,000	452,500
Issuance of warrants for services	231,715
Accretion of discount on note receivable	(21,521)	(27,355)
Change in operating assets and liabilities:
Accounts receivable	(2,402,205)	(65,370)
Prepaid expenses and other current assets	(928,914)	(254,736)
Deposits	(46,331)	(19,876)
Accounts payable	(81,168)	446,787
Accrued expenses	796,565	982,506
Contract liability	758,475	196,145
Deferred rent	196,035	148,387
Net Cash Used in Operating Activities	(11,612,914)	(2,061,948)
Cash flows from investing activities:
Acquisition of property and equipment	(2,013,352)	(25,011)
Payment for business acquisition	(225,000)
Principal collections under note receivable	12,699
Net Cash Used in Investing Activities	(2,225,653)	(25,011)
Cash flows from financing activities:
Proceeds from issuance of Common Stock	27,930,000
Principal payments on debt	(25,000)
Payment for issuance costs	(2,237,566)
Proceeds from issuance of debt		1,265,067
Redemption of preferred stock	(1,500,000)	(150,000)
Proceeds from issuance of preferred stock		2,102,499
Payments for deferred offering costs		(49,831)
Net Cash Provided by Financing Activities	24,167,434	3,167,735
Net increase in cash and cash equivalents	10,328,867	1,080,776
Cash and cash equivalents, beginning of period	18,205,668	469,353
Cash and cash equivalents, end of period	28,534,535	1,550,129
Supplemental disclosure of cash flow information
Cash paid for interest	9,821	21,530
Cash paid for income taxes
Supplemental disclosure of non-cash
Fair value of warrants issued in asset purchase	136,326
Fair value of warrants issued in business acquisition	171,689
Fair value of warrants issued to underwriters in connection with follow-on offering	1,486,451
Exchange of debt to preferred stock		2,824,535
Accretion of redeemable preferred stock		750,000
Conversion of debt to Common Stock		770,000
Common Stock issued for payment of interest		26,068
Preferred stock issued for payment of interest		$ 102,422